Bain Capital Life Sciences III General Partner, LLC
Insider CIK 1952106 · HTFL 10% owner · NAMS 10% owner · KYTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| HTFL Heartflow, Inc. | S Sale | 2026-04-30 | 2026-04-30 | 56,224 | $30.05 | $1.69M | 8,448,158 | SEC↗ |
| HTFL Heartflow, Inc. | S Sale | 2026-04-30 | 2026-04-30 | 892,533 | $29.18 | $26.04M | 8,504,382 | SEC↗ |
| HTFL Heartflow, Inc. | S Sale | 2026-04-29 | 2026-04-30 | 797,133 | $29.37 | $23.41M | 9,396,915 | SEC↗ |
| HTFL Heartflow, Inc. | S Sale | 2026-04-28 | 2026-04-30 | 254,110 | $30.51 | $7.75M | 10,194,048 | SEC↗ |
| HTFL Heartflow, Inc. | S Sale | 2026-02-04 | 2026-02-06 | 2,000,000 | $28.05 | $56.10M | 10,448,158 | SEC↗ |
| HTFL Heartflow, Inc. | C Conversion deriv | 2025-08-11 | 2025-08-13 | 35,081,564 | — | $0 | 0 | SEC↗ |
| HTFL Heartflow, Inc. | C Conversion deriv | 2025-08-11 | 2025-08-13 | 0 | — | $0 | 0 | SEC↗ |
| HTFL Heartflow, Inc. | C Conversion | 2025-08-11 | 2025-08-13 | 433,924 | $15.20 | $6.60M | 12,448,158 | SEC↗ |
| HTFL Heartflow, Inc. | C Conversion | 2025-08-11 | 2025-08-13 | 12,014,234 | — | $0 | 12,014,234 | SEC↗ |
| NAMS NewAmsterdam Pharma Co N.V | P Buy deriv | 2024-12-13 | 2024-12-17 | 1,632,653 | $24.50 | $40.00M | 1,632,653 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion deriv | 2024-02-12 | 2024-02-14 | 12,351,087 | — | $0 | 0 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | P Buy | 2024-02-12 | 2024-02-14 | 450,000 | $22.00 | $9.90M | 3,163,868 | SEC↗ |
| KYTX Kyverna Therapeutics, Inc. | C Conversion | 2024-02-12 | 2024-02-14 | 2,713,868 | — | $0 | 2,713,868 | SEC↗ |